Arcutis Biotherapeutics, Inc.
ARQT
Ранг среди акций
#3988
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Цена акции
$32.88
Рыночная капитализация
$4.13B
Изменение (1 день)
3.11%
Изменение (1 год)
57.49%
Страна
US
Торговля Arcutis Biotherapeutics, Inc. (ARQT)
Категория
Healthcare
История дроблений акций Arcutis Biotherapeutics, Inc. (ARQT)
Акции Arcutis Biotherapeutics, Inc. (символ: ARQT) прошли через 0 дроблений.
Последнее дробление произошло Oct 20, 2026.
Одна акция ARQT, купленная до Oct 20, 2026, сейчас соответствует 0 акциям ARQT.
Последнее дробление произошло Oct 20, 2026.
Одна акция ARQT, купленная до Oct 20, 2026, сейчас соответствует 0 акциям ARQT.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
